Loading...

Wesley Y Naritoku, MD, PhD

TitleProfessor of Clinical Pathology
InstitutionUniversity of Southern California
DepartmentPathology
AddressCT 1200 North State Street
Off Campus
Los Angeles CA 90033
Phone+1 323 409 6689
vCardDownload vCard
    Other Positions
    TitleDirector of Residency Program At LAC+USC Medical Center


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Davis GG, Winters GL, Fyfe BS, Hooper JE, Iezzoni JC, Johnson RL, Markwood PS, Naritoku WY, Nashelsky M, Sampson BA, Steinberg JJ, Stubbs JR, Timmons C, Hoffman RD. Report and Recommendations of the Association of Pathology Chairs' Autopsy Working Group. Acad Pathol. 2018 Jan-Dec; 5:2374289518793988. PMID: 30186954.
      View in: PubMed
    2. Wei CH, Pettersson J, Campan M, Chopra S, Naritoku W, Martin SE, Ward PM. Gain of TP53 Mutation in Imatinib-treated SDH-Deficient Gastrointestinal Stromal Tumor and Clinical Utilization of Targeted Next-generation Sequencing Panel for Therapeutic Decision Support. Appl Immunohistochem Mol Morphol. 2016 Dec 23. PMID: 28027118.
      View in: PubMed
    3. Naritoku WY, Powell SZ, Black-Schaffer WS. Evolution of the Pathology Residency Curriculum: Preparing for a Positive Future. Acad Pathol. 2016 Jan-Dec; 3:2374289516667746. PMID: 28725779.
      View in: PubMed
    4. Naritoku WY, Timmons CF. The Pathologist Pipeline: Implications of Changes for Programs and Post-Sophomore Fellowships-Program Directors' Section Perspective. Acad Pathol. 2016 Jan-Dec; 3:2374289516646117. PMID: 28725767.
      View in: PubMed
    5. McGoey R, Naritoku WY, Furlong MA. Identifying the Challenges of "Small" Pathology Residency Programs and Creating Collaborative Solutions. Acad Pathol. 2016 Jan-Dec; 3:2374289516643541. PMID: 28725764.
      View in: PubMed
    6. Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, Taylor CR, Ray PS. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. J Natl Cancer Inst. 2015 Aug; 107(8). PMID: 26041837; PMCID: PMC4554196.
    7. Naritoku WY, Black-Schaffer WS. Cytopathology fellowship milestones. Cancer Cytopathol. 2014 Dec; 122(12):859-65. PMID: 25236620.
      View in: PubMed
    8. Iezzoni JC, Ewton A, Chévez-Barrios P, Moore S, Thorsen LM, Naritoku WY. Selective pathology fellowships: diverse, innovative, and valuable subspecialty training. Arch Pathol Lab Med. 2014 Apr; 138(4):518-25. PMID: 24678683.
      View in: PubMed
    9. Naritoku WY, Alexander CB. Pathology milestones. J Grad Med Educ. 2014 Mar; 6(1 Suppl 1):180-1. PMID: 24701281; PMCID: PMC3966611.
    10. Naritoku WY, Vasovic L, Steinberg JJ, Prystowsky MB, Powell SZ. Anatomic and clinical pathology boot camps: filling pathology-specific gaps in undergraduate medical education. Arch Pathol Lab Med. 2014 Mar; 138(3):316-21. PMID: 24576025.
      View in: PubMed
    11. Naritoku WY, Alexander CB, Bennett BD, Black-Schaffer WS, Brissette MD, Grimes MM, Hoffman RD, Hunt JL, Iezzoni JC, Johnson R, Kozel J, Mendoza RM, Post MD, Powell SZ, Procop GW, Steinberg JJ, Thorsen LM, Nestler SP. The pathology milestones and the next accreditation system. Arch Pathol Lab Med. 2014 Mar; 138(3):307-15. PMID: 24576024.
      View in: PubMed
    12. Chaiwun B, Sukhamwang N, Trakultivakorn H, Saha B, Young L, Tsao-Wei D, Naritoku WY, Groshen S, Taylor CR, Imam SA. GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases. Br J Cancer. 2011 Oct 11; 105(8):1224-9. PMID: 21897388; PMCID: PMC3208492.
    13. Guo J, Young SK, Lorenzo CR, Lee CM, Kanel GC, Brynes RK, Chandrasoma P, Naritoku WY. Phlegmonous gastritis in a patient with myeloid sarcoma: a case report. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):458-62. PMID: 19644358.
      View in: PubMed
    14. Saha B, Kaur P, Tsao-Wei D, Naritoku WY, Groshen S, Datar RH, Jones LW, Imam SA. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate. 2008 Nov 01; 68(15):1681-8. PMID: 18712716.
      View in: PubMed
    15. Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku WY, Groshen S, Jones LW, Imam SA. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate. 2008 Jan 01; 68(1):78-84. PMID: 18008331.
      View in: PubMed
    16. Saha B, Chaiwun B, Imam SS, Tsao-Wei DD, Groshen S, Naritoku WY, Imam SA. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res. 2007 Nov-Dec; 27(6B):3903-8. PMID: 18225549.
      View in: PubMed
    17. Saha B, Chaiwun B, Tsao-Wei DD, Groshen SL, Naritoku WY, Atkinson RD, Taylor CR, Imam SA. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol. 2007 Jul; 26(3):214-22. PMID: 17581401.
      View in: PubMed
    18. Horowitz RE, Naritoku WY. The autopsy as a performance measure and teaching tool. Hum Pathol. 2007 May; 38(5):688-695. PMID: 17376512.
      View in: PubMed
    19. Laine LA, Nathwani RA, Naritoku W. The effect of GI bleeding on Helicobacter pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later. Gastrointest Endosc. 2005 Dec; 62(6):853-9. PMID: 16301025.
      View in: PubMed
    20. Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Anticancer Res. 2004 Jul-Aug; 24(4):2391-400. PMID: 15330189.
      View in: PubMed
    21. Horowitz RE, Naritoku W, Wagar EA. Management training for pathology residents: a regional approach. Arch Pathol Lab Med. 2004 Jan; 128(1):59-63. PMID: 14692810.
      View in: PubMed
    22. Baltayan A, Naritoku WY, Chaiwun B, Tsao-Wei DD, Groshen S, Hern RA, Gusterson BA, Taylor CR, Imam SA. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Anticancer Res. 2002 Sep-Oct; 22(5):2933-7. PMID: 12530020.
      View in: PubMed
    23. Formenti SC, Spicer D, Skinner K, Cohen D, Groshen S, Bettini A, Naritoku W, Press M, Salonga D, Tsao-Wei D, Danenberg K, Danenberg P. Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):397-405. PMID: 11872285.
      View in: PubMed
    24. Liu D, Naritoku WY, Tsao-Wei D, Groshen S, Neville MA, Taylor CR, Cote RJ, Imam SA. LEA.135 expression: an independent and favorable prognostic biomarker for patients with primary invasive breast cancer. Int J Cancer. 2000 May 20; 89(3):224-9. PMID: 10861497.
      View in: PubMed
    25. Liu D, Baltayan A, Naritoku WY, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma. Anticancer Res. 2000 May-Jun; 20(3A):1451-61. PMID: 10928056.
      View in: PubMed
    26. Datar RH, Naritoku WY, Li P, Tsao-Wei D, Groshen S, Taylor CR, Imam SA. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas. Gynecol Oncol. 1999 Sep; 74(3):338-45. PMID: 10479490.
      View in: PubMed
    27. Naritoku WY, Datar RH, Li P, Groshen SL, Taylor CR, Imam SA. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells. Cancer. 1999 Aug 25; 87(4):210-5. PMID: 10455209.
      View in: PubMed
    28. Cohen H, Rose S, Lewin DN, Retama B, Naritoku W, Johnson C, Bautista L, Crowe H, Pronovost A. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori. Helicobacter. 1999 Mar; 4(1):49-53. PMID: 10352087.
      View in: PubMed
    29. Laine L, Lewin DN, Naritoku W, Cohen H. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1997 Jun; 45(6):463-7. PMID: 9199901.
      View in: PubMed
    30. Bennett DR, Baird CJ, Chan KM, Crookes PF, Bremner CG, Gottlieb MM, Naritoku WY. Zinc toxicity following massive coin ingestion. Am J Forensic Med Pathol. 1997 Jun; 18(2):148-53. PMID: 9185931.
      View in: PubMed
    31. Laine L, Lewin D, Naritoku W, Estrada R, Cohen H. Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1996 Nov; 44(5):523-6. PMID: 8934155.
      View in: PubMed
    32. Yang R, Naritoku W, Laine L. Prospective, randomized comparison of disposable and reusable biopsy forceps in gastrointestinal endoscopy. Gastrointest Endosc. 1994 Nov-Dec; 40(6):671-4. PMID: 7859962.
      View in: PubMed
    33. Krasne DL, Naritoku WY, Cosgrove MM. Diagnosis of syncytial (lacunar cell-predominant) nodular sclerosing Hodgkin's disease by fine needle aspiration. A case report. Acta Cytol. 1993 May-Jun; 37(3):418-22. PMID: 7684549.
      View in: PubMed
    34. Naritoku WY, Taylor CR. Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast. J Urol. 1983 Aug; 130(2):365-7. PMID: 6192256.
      View in: PubMed
    35. Naritoku WY, Taylor CR. A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: an evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase. J Histochem Cytochem. 1982 Mar; 30(3):253-60. PMID: 7037942.
      View in: PubMed